Safety, specificity and immunogenicity of a PrP^Sc-specific prion vaccine based on the YYR disease specific epitope

References

• Prusiner SB. Molecular biology of prion diseases. Science 1991; 252:1515 - 22; http://dx.doi.org/10.1126/science.1675487; PMID: 1675487
   PubMed Web of Science ®Google Scholar
• Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043 - 4; http://dx.doi.org/10.1038/2151043a0; PMID: 4964084
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 44; http://dx.doi.org/10.1126/science.6801762; PMID: 6801762
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11 - 40; http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154326; PMID: 18233951
   PubMed Web of Science ®Google Scholar
• Hunter N, Houston F, Foster J, Goldmann W, Drummond D, Parnham D, Kennedy I, Green A, Stewart P, Chong A. Susceptibility of young sheep to oral infection with bovine spongiform encephalopathy decreases significantly after weaning. J Virol 2012; 86:11856 - 62; http://dx.doi.org/10.1128/JVI.01573-12; PMID: 22915816
   PubMed Web of Science ®Google Scholar
• Kimberlin RH, Wilesmith JW. Bovine spongiform encephalopathy. Epidemiology, low dose exposure and risks. Ann N Y Acad Sci 1994; 724:210 - 20; http://dx.doi.org/10.1111/j.1749-6632.1994.tb38911.x; PMID: 8030941
   PubMed Web of Science ®Google Scholar
• Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, Warren RJ, Mason GL, Hays SA, Hayes-Klug J, Seelig DM, et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 2006; 314:133 - 6; http://dx.doi.org/10.1126/science.1132661; PMID: 17023660
   PubMed Web of Science ®Google Scholar
• Jeffrey M, Ryder S, Martin S, Hawkins SA, Terry L, Berthelin-Baker C, Bellworthy SJ. Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol 2001; 124:280 - 9; http://dx.doi.org/10.1053/jcpa.2001.0465; PMID: 11437504
   PubMed Web of Science ®Google Scholar
• Race R, Jenny A, Sutton D. Scrapie infectivity and proteinase K-resistant prion protein in sheep placenta, brain, spleen, and lymph node: implications for transmission and antemortem diagnosis. J Infect Dis 1998; 178:949 - 53; http://dx.doi.org/10.1086/515669; PMID: 9806020
   PubMed Web of Science ®Google Scholar
• Silveira JR, Caughey B, Baron GS. Prion Protein and the Molecular Features of Transmissible Spongiform Encephalopathy Agents. In: … Cow Disease and Related Spongiform…. Berlin, Heidelberg: Springer Berlin Heidelberg; 2004. pages 1–50.
   Google Scholar
• van Raamsdonk LWD. Holst von C, Baeten V, Berben G, Boix A, de Jong J. New developments in the detection and identification of processed animal proteins in feeds. Anim Feed Sci Technol 2007; 133:63 - 83; http://dx.doi.org/10.1016/j.anifeedsci.2006.08.004
   Web of Science ®Google Scholar
• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519 - 50; http://dx.doi.org/10.1146/annurev.neuro.24.1.519; PMID: 11283320
   PubMed Web of Science ®Google Scholar
• Nathanson N, Wilesmith J, Griot C. Bovine spongiform encephalopathy (BSE): causes and consequences of a common source epidemic. Am J Epidemiol 1997; 145:959 - 69; http://dx.doi.org/10.1093/oxfordjournals.aje.a009064; PMID: 9169904
   PubMed Web of Science ®Google Scholar
• Williams ES. Chronic wasting disease. Vet Pathol 2005; 42:530 - 49; http://dx.doi.org/10.1354/vp.42-5-530; PMID: 16145200
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ. A prion disease of cervids: chronic wasting disease. Vet Res 2008; 39:41; http://dx.doi.org/10.1051/vetres:2008018; PMID: 18381058
   PubMed Web of Science ®Google Scholar
• Aguzzi A. Staining, straining and restraining prions. Nat Neurosci 2008; 11:1239 - 40; http://dx.doi.org/10.1038/nn1108-1239; PMID: 18956007
   PubMed Web of Science ®Google Scholar
• Li L, Napper S, Cashman NR. Immunotherapy for prion diseases: opportunities and obstacles. Immunotherapy 2010; 2:269 - 82; http://dx.doi.org/10.2217/imt.10.3; PMID: 20635933
   PubMed Web of Science ®Google Scholar
• Williams ES, Miller MW, Kreeger TJ, Kahn RH, Thorne ET. Chronic wasting disease of deer and elk: a review with recommendations for management. J Wildl Manage 2002; 66:551 - 63; http://dx.doi.org/10.2307/3803123
   Web of Science ®Google Scholar
• Belay ED, Gambetti P, Schonberger LB, Parchi P, Lyon DR, Capellari S, McQuiston JH, Bradley K, Dowdle G, Crutcher JM, et al. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol 2001; 58:1673 - 8; http://dx.doi.org/10.1001/archneur.58.10.1673; PMID: 11594928
   PubMed Web of Science ®Google Scholar
• Belay ED, Maddox RA, Williams ES, Miller MW, Gambetti P, Schonberger LB. Chronic wasting disease and potential transmission to humans. Emerg Infect Dis 2004; 10:977 - 84; http://dx.doi.org/10.3201/eid1006.031082; PMID: 15207045
   PubMed Web of Science ®Google Scholar
• Kong Q, Huang S, Zou W, Vanegas D, Wang M, Wu D, Yuan J, Zheng M, Bai H, Deng H, et al. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 2005; 25:7944 - 9; http://dx.doi.org/10.1523/JNEUROSCI.2467-05.2005; PMID: 16135751
   PubMed Web of Science ®Google Scholar
• Race B, Meade-White KD, Miller MW, Barbian KD, Rubenstein R, LaFauci G, Cervenakova L, Favara C, Gardner D, Long D, et al. Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis 2009; 15:1366 - 76; http://dx.doi.org/10.3201/eid1509.090253; PMID: 19788803
   PubMed Web of Science ®Google Scholar
• Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L, Linehan J, Simmons M, Webb P, Bellerby P, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 2013; 347:f5675; http://dx.doi.org/10.1136/bmj.f5675; PMID: 24129059
   PubMed Web of Science ®Google Scholar
• Hedlin P, Taschuk R, Potter A, Griebel P, Napper S. Detection and control of prion diseases in food animals. ISRN Vet Sci 2012; 2012:254739; http://dx.doi.org/10.5402/2012/254739; PMID: 23738120
   PubMedGoogle Scholar
• Castilla J, Gonzalez-Romero D, Saá P, Morales R, De Castro J, Soto C. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 2008; 134:757 - 68; http://dx.doi.org/10.1016/j.cell.2008.07.030; PMID: 18775309
   PubMed Web of Science ®Google Scholar
• Hamir AN, Kehrli ME Jr., Kunkle RA, Greenlee JJ, Nicholson EM, Richt JA, Miller JM, Cutlip RC. Experimental interspecies transmission studies of the transmissible spongiform encephalopathies to cattle: comparison to bovine spongiform encephalopathy in cattle. J Vet Diagn Invest 2011; 23:407 - 20; http://dx.doi.org/10.1177/1040638711403404; PMID: 21908269
   PubMed Web of Science ®Google Scholar
• Almberg ES, Cross PC, Johnson CJ, Heisey DM, Richards BJ. Modeling routes of chronic wasting disease transmission: environmental prion persistence promotes deer population decline and extinction. PLoS One 2011; 6:e19896; http://dx.doi.org/10.1371/journal.pone.0019896; PMID: 21603638
   PubMed Web of Science ®Google Scholar
• Wasserberg G, Osnas EE, Rolley RE, Samuel MD. Host culling as an adaptive management tool for chronic wasting disease in white-tailed deer: a modelling study. J Appl Ecol 2009; 46:457 - 66; http://dx.doi.org/10.1111/j.1365-2664.2008.01576.x; PMID: 19536340
   PubMed Web of Science ®Google Scholar
• Roettger Y, Du Y, Bacher M, Zerr I, Dodel R, Bach J-P. Immunotherapy in prion disease. Nat Rev Neurol 2013; 9:98 - 105; http://dx.doi.org/10.1038/nrneurol.2012.258; PMID: 23247613
   PubMed Web of Science ®Google Scholar
• Enari M, Flechsig E, Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A 2001; 98:9295 - 9; http://dx.doi.org/10.1073/pnas.151242598; PMID: 11470893
   PubMed Web of Science ®Google Scholar
• Perrier V, Solassol J, Crozet C, Frobert Y, Mourton-Gilles C, Grassi J, Lehmann S. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J Neurochem 2004; 89:454 - 63; http://dx.doi.org/10.1111/j.1471-4159.2004.02356.x; PMID: 15056288
   PubMed Web of Science ®Google Scholar
• White AR, Hawke SH. Immunotherapy as a therapeutic treatment for neurodegenerative disorders. J Neurochem 2003; 87:801 - 8; http://dx.doi.org/10.1046/j.1471-4159.2003.02064.x; PMID: 14622111
   PubMed Web of Science ®Google Scholar
• Sigurdsson EM, Brown DR, Daniels M, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T. Immunization delays the onset of prion disease in mice. Am J Pathol 2002; 161:13 - 7; http://dx.doi.org/10.1016/S0002-9440(10)64151-X; PMID: 12107084
   PubMed Web of Science ®Google Scholar
• Sigurdsson EM, Sy M-S, Li R, Scholtzova H, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci Lett 2003; 336:185 - 7; http://dx.doi.org/10.1016/S0304-3940(02)01192-8; PMID: 12505623
   PubMed Web of Science ®Google Scholar
• Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001; 412:739 - 43; http://dx.doi.org/10.1038/35089090; PMID: 11507642
   PubMed Web of Science ®Google Scholar
• Müller-Schiffmann A, Korth C. Vaccine approaches to prevent and treat prion infection : progress and challenges. BioDrugs 2008; 22:45 - 52; http://dx.doi.org/10.2165/00063030-200822010-00005; PMID: 18215090
   PubMed Web of Science ®Google Scholar
• Trevitt CR, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006; 129:2241 - 65; http://dx.doi.org/10.1093/brain/awl150; PMID: 16816391
   PubMed Web of Science ®Google Scholar
• Hanan E, Goren O, Eshkenazy M, Solomon B. Immunomodulation of the human prion peptide 106-126 aggregation. Biochem Biophys Res Commun 2001; 280:115 - 20; http://dx.doi.org/10.1006/bbrc.2000.4097; PMID: 11162487
   PubMed Web of Science ®Google Scholar
• Koller MF, Grau T, Christen P. Induction of antibodies against murine full-length prion protein in wild-type mice. J Neuroimmunol 2002; 132:113 - 6; http://dx.doi.org/10.1016/S0165-5728(02)00316-8; PMID: 12417440
   PubMed Web of Science ®Google Scholar
• Rosset MB, Ballerini C, Grégoire S, Metharom P, Carnaud C, Aucouturier P. Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice. J Immunol 2004; 172:5168 - 74; PMID: 15100253
   PubMed Web of Science ®Google Scholar
• Polymenidou M, Heppner FL, Pellicioli EC, Urich E, Miele G, Braun N, Wopfner F, Schätzl HM, Becher B, Aguzzi A. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc Natl Acad Sci U S A 2004; 101:Suppl 2 14670 - 6; http://dx.doi.org/10.1073/pnas.0404772101; PMID: 15292505
   PubMed Web of Science ®Google Scholar
• Schwarz A, Krätke O, Burwinkel M, Riemer C, Schultz J, Henklein P, Bamme T, Baier M. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett 2003; 350:187 - 9; http://dx.doi.org/10.1016/S0304-3940(03)00907-8; PMID: 14550926
   PubMed Web of Science ®Google Scholar
• Gilch S, Schätzl HM. Promising developments bringing prion diseases closer to therapy and prophylaxis. Trends Mol Med 2003; 9:367 - 9; http://dx.doi.org/10.1016/S1471-4914(03)00144-8; PMID: 13129701
   PubMed Web of Science ®Google Scholar
• Gerdts V, Mutwiri G, Richards J, van Drunen Littel-van den Hurk S, Potter AA. Carrier molecules for use in veterinary vaccines. Vaccine 2013; 31:596 - 602; http://dx.doi.org/10.1016/j.vaccine.2012.11.067; PMID: 23219438
   PubMed Web of Science ®Google Scholar
• Manns JG, Barker C, Attah-Poku SK. The design, production, purification, and testing of a chimeric antigen protein to be used as an immunosterilant in domestic animals. Can J Chem 1997; 75:829 - 33; http://dx.doi.org/10.1139/v97-100
   Web of Science ®Google Scholar
• Hedlin PD, Cashman NR, Li L, Gupta J, Babiuk LA, Potter AA, Griebel P, Napper S. Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses. Vaccine 2010; 28:981 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.10.134; PMID: 19925901
   PubMed Web of Science ®Google Scholar
• Solforosi L, Criado JR, McGavern DB, Wirz S, Sánchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004; 303:1514 - 6; http://dx.doi.org/10.1126/science.1094273; PMID: 14752167
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289:1925 - 8; http://dx.doi.org/10.1126/science.289.5486.1925; PMID: 10988071
   PubMed Web of Science ®Google Scholar
• Sonati T, Reimann RR, Falsig J, Baral PK, O’Connor T, Hornemann S, Yaganoglu S, Li B, Herrmann US, Wieland B, et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 2013; 501:102 - 6; http://dx.doi.org/10.1038/nature12402; PMID: 23903654
   PubMed Web of Science ®Google Scholar
• James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Mehlhorn I, Prusiner SB, et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A 1997; 94:10086 - 91; http://dx.doi.org/10.1073/pnas.94.19.10086; PMID: 9294167
   PubMed Web of Science ®Google Scholar
• Zou W-Q, Cashman NR. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form. J Biol Chem 2002; 277:43942 - 7; http://dx.doi.org/10.1074/jbc.M203611200; PMID: 12161431
   PubMed Web of Science ®Google Scholar
• Paramithiotis E, Pinard M, Lawton T, LaBoissiere S, Leathers VL, Zou W-Q, Estey LA, Lamontagne J, Lehto MT, Kondejewski LH, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat Med 2003; 9:893 - 9; http://dx.doi.org/10.1038/nm883; PMID: 12778138
   PubMed Web of Science ®Google Scholar
• Cashman NR. Antibodies And Epitopes Specific To Misfolded Prion Protein. 2010; United States patent US 20120107321.
   Google Scholar
• Guest W, Cashman N, Plotkin S. Structure-Based Prediction of Unstable Regions in Proteins: Applications to Protein Misfolding Diseases. Bull Am Phys Soc 2009; 54
   Google Scholar
• Sigurdson CJ, Aguzzi A. Chronic wasting disease. Biochim Biophys Acta 2007; 1772:610 - 8; http://dx.doi.org/10.1016/j.bbadis.2006.10.010; PMID: 17223321
   PubMed Web of Science ®Google Scholar
• Gossert AD, Bonjour S, Lysek DA, Fiorito F, Wüthrich K. Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci U S A 2005; 102:646 - 50; http://dx.doi.org/10.1073/pnas.0409008102; PMID: 15647363
   PubMed Web of Science ®Google Scholar
• Soto C. Constraining the loop, releasing prion infectivity. Proc Natl Acad Sci U S A 2009; 106:10 - 1; http://dx.doi.org/10.1073/pnas.0811625106; PMID: 19118191
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Zerbi P, Voigtländer T, Strohschneider M, Trabattoni G, Hainfellner JA, Budka H. The prion protein in human neurodegenerative disorders. Neurosci Lett 2002; 329:269 - 72; http://dx.doi.org/10.1016/S0304-3940(02)00668-7; PMID: 12183028
   PubMed Web of Science ®Google Scholar
• Nitrini R, Rosemberg S, Passos-Bueno MR, da Silva LS, Iughetti P, Papadopoulos M, Carrilho PM, Caramelli P, Albrecht S, Zatz M, et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 1997; 42:138 - 46; http://dx.doi.org/10.1002/ana.410420203; PMID: 9266722
   PubMed Web of Science ®Google Scholar
• Kiachopoulos S, Bracher A, Winklhofer KF, Tatzelt J. Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. J Biol Chem 2005; 280:9320 - 9; http://dx.doi.org/10.1074/jbc.M412525200; PMID: 15591591
   PubMed Web of Science ®Google Scholar
• Chebaro Y, Derreumaux P. The conversion of helix H2 to beta-sheet is accelerated in the monomer and dimer of the prion protein upon T183A mutation. J Phys Chem B 2009; 113:6942 - 8; http://dx.doi.org/10.1021/jp900334s; PMID: 19371053
   PubMed Web of Science ®Google Scholar
• van der Kamp MW, Daggett V. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. J Mol Biol 2010; 404:732 - 48; http://dx.doi.org/10.1016/j.jmb.2010.09.060; PMID: 20932979
   PubMed Web of Science ®Google Scholar
• Rogers M, Taraboulos A, Scott M, Groth D, Prusiner SB. Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1990; 1:101 - 9; http://dx.doi.org/10.1093/glycob/1.1.101; PMID: 1983782
   PubMedGoogle Scholar
• Madampage CA, Määttänen P, Marciniuk K, Brownlie R, Andrievskaia O, Potter A, Cashman NR, Lee JS, Napper S. Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases. Prion 2013; 7:301 - 11; http://dx.doi.org/10.4161/pri.25148; PMID: 23787697
   PubMed Web of Science ®Google Scholar
• Li L, Guest W, Huang A, Plotkin SS, Cashman NR. Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding. Protein Eng Des Sel 2009; 22:523 - 9; http://dx.doi.org/10.1093/protein/gzp038; PMID: 19602568
   PubMed Web of Science ®Google Scholar
• Chianini F, Fernández-Borges N, Vidal E, Gibbard L, Pintado B, de Castro J, Priola SA, Hamilton S, Eaton SL, Finlayson J, et al. Rabbits are not resistant to prion infection. Proc Natl Acad Sci U S A 2012; 109:5080 - 5; http://dx.doi.org/10.1073/pnas.1120076109; PMID: 22416127
   PubMed Web of Science ®Google Scholar
• Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 1996; 15:1255 - 64; PMID: 8635458
   PubMed Web of Science ®Google Scholar
• Määttänen P, Taschuk R, Ross L, Marciniuk K, Bertram L, Potter A, Cashman NR, Napper S. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice. Prion 2013; 7:434 - 9; http://dx.doi.org/10.4161/pri.26639; PMID: 24105298
   PubMed Web of Science ®Google Scholar